These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 16397057)
1. Celecoxib decreases Ki-67 proliferative index in active smokers. Mao JT; Fishbein MC; Adams B; Roth MD; Goodglick L; Hong L; Burdick M; Strieter ER; Holmes C; Tashkin DP; Dubinett SM Clin Cancer Res; 2006 Jan; 12(1):314-20. PubMed ID: 16397057 [TBL] [Abstract][Full Text] [Related]
2. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study. Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502 [TBL] [Abstract][Full Text] [Related]
3. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers. Mao JT; Roth MD; Serio KJ; Baratelli F; Zhu L; Holmes EC; Strieter RM; Dubinett SM Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5835-41. PubMed ID: 14676104 [TBL] [Abstract][Full Text] [Related]
4. Lung cancer chemoprevention with celecoxib in former smokers. Mao JT; Roth MD; Fishbein MC; Aberle DR; Zhang ZF; Rao JY; Tashkin DP; Goodglick L; Holmes EC; Cameron RB; Dubinett SM; Elashoff R; Szabo E; Elashoff D Cancer Prev Res (Phila); 2011 Jul; 4(7):984-93. PubMed ID: 21733822 [TBL] [Abstract][Full Text] [Related]
5. Pilot randomized phase II study of celecoxib in oral premalignant lesions. Papadimitrakopoulou VA; William WN; Dannenberg AJ; Lippman SM; Lee JJ; Ondrey FG; Peterson DE; Feng L; Atwell A; El-Naggar AK; Nathan CO; Helman JI; Du B; Yueh B; Boyle JO Clin Cancer Res; 2008 Apr; 14(7):2095-101. PubMed ID: 18381950 [TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant therapy with celecoxib to women with early stage breast cancer. Tfayli A; Yang J; Kojouri K; Kesserwan C; Jafari M; Ozer H Neoplasma; 2008; 55(2):122-6. PubMed ID: 18237249 [TBL] [Abstract][Full Text] [Related]
7. A pilot surrogate endpoint biomarker study of celecoxib in oral premalignant lesions. Wirth LJ; Krane JF; Li Y; Othus M; Moran AE; Dorfman DM; Norris CM; Goguen L; Posner MR; Haddad RI; Bertagnolli MM Cancer Prev Res (Phila); 2008 Oct; 1(5):339-48. PubMed ID: 19138978 [TBL] [Abstract][Full Text] [Related]
8. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients. Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC; Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247 [TBL] [Abstract][Full Text] [Related]
9. Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease. Miller YE; Blatchford P; Hyun DS; Keith RL; Kennedy TC; Wolf H; Byers T; Bunn PA; Lewis MT; Franklin WA; Hirsch FR; Kittelson J Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2425-31. PubMed ID: 18006932 [TBL] [Abstract][Full Text] [Related]
10. Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide. Mao JT; Tsu IH; Dubinett SM; Adams B; Sarafian T; Baratelli F; Roth MD; Serio KJ Clin Cancer Res; 2004 Oct; 10(20):6872-8. PubMed ID: 15501964 [TBL] [Abstract][Full Text] [Related]
11. More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib. Hinz B; Dormann H; Brune K Arthritis Rheum; 2006 Jan; 54(1):282-91. PubMed ID: 16385545 [TBL] [Abstract][Full Text] [Related]
12. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis. Olivares C; Bilotas M; Buquet R; Borghi M; Sueldo C; Tesone M; Meresman G Hum Reprod; 2008 Dec; 23(12):2701-8. PubMed ID: 18716040 [TBL] [Abstract][Full Text] [Related]
13. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats]. Tang BD; Zeng ZR; Hu PJ Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761 [TBL] [Abstract][Full Text] [Related]
14. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer. Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis. Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239 [TBL] [Abstract][Full Text] [Related]